| ²é¿´: 2158 | »Ø¸´: 3 | |||
ÍôæÃ·ãҶгæ (ÕýʽдÊÖ)
|
[ÇóÖú]
Duplex-specific nuclease (DSN)µÄ×÷Óà ÒÑÓÐ1È˲ÎÓë
|
| ÇëÎÊDuplex-specific nuclease (DSN)Ö÷ÒªÊÇÔõÑù¼ôÇÐDNAµÄ£¬ËüÄÜ·ñ¼ôµôGËÄÁ¬ÌåÄØ£¿Ð»Ð»£¡ |
» ²ÂÄãϲ»¶
Wnt-C59£ºPORCN°ÐÏò»¯Ñ§Ì½Õ룬WntÐźÅͨ·×è¶Ï»úÖÆÓë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Fexaramine£º³¦µÀÏÞÖÆÐÔFXR»¯Ñ§Ì½Õ룬½á¹¹ÌØÕ÷ÓëÐźÅͨ·Ñо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ61È˻ظ´
NVS-STG2£º°ÐÏòSTING¿çĤÓòµÄ·Ö×Ó½ºÀ༤¶¯¼Á£¬½á¹¹ÌØÕ÷Óë¹Ñ¾Û»¯»úÖÆÑо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
DOTA-GPC3ëÄ£¨CAS 3066439-94-6£©£ºË«¹¦ÄÜ·Ö×Ó̽ÕëǰÌåµÄ½á¹¹ÌØÕ÷Óë±ê¼ÇÓ¦ÓýâÎö
ÒѾÓÐ0È˻ظ´
¿ÆÑÐÓà TLR7/8 Ë«¼¤¶¯¼ÁÔõôѡ£¿ÏÖ»õÓëÖÊ¿ØÒªµã
ÒѾÓÐ0È˻ظ´
SEL120-34A HCl£ºCDK8/CDK19¸ßÑ¡ÔñÐÔ¼¤Ã¸ÒÖÖÆ¼Á
ÒѾÓÐ0È˻ظ´
ÇâÑõ»¯¼Ø»î»¯²Ù×÷
ÒѾÓÐ18È˻ظ´
É¢½ð
ÒѾÓÐ68È˻ظ´
ÉúÎïÖʳ¬¼¶µçÈÝÆ÷
ÒѾÓÐ0È˻ظ´

nakerunner
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 1011.6
- É¢½ð: 25
- Ìû×Ó: 132
- ÔÚÏß: 165.9Сʱ
- ³æºÅ: 287501
- ×¢²á: 2006-10-21
- ÐÔ±ð: GG
- רҵ: ÁÙ´²¼ìÑéм¼Êõ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÍôæÃ·ãÒ¶: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú 2015-06-14 16:36:34
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÍôæÃ·ãÒ¶: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú 2015-06-14 16:36:34
|
DSNÖ÷Òª¼ôÇÐDNA-RNA¸´ºÏÎïÖеÄDNA£¬µ±È»¶ÔÓÚDNA-DNAÒ²ÓÐÒ»¶¨µÄ×÷Óá£Õâ¸ö¿ÉÒÔͨ¹ý¿ØÖÆ·´Ó¦Ìõ¼þÀ´µ÷½Ú¡£ ÖÁÓÚGËÄÁ¬ÌåµÄÎÊÌ⣬ÐèҪʵÑéÀ´ÑéÖ¤¡£ ÍÆ¼öһƪDSNµÄ×îÐÂϵͳÐÔ×ÛÊö Duplex-specific nuclease-mediated bioanalysis (Trend Biotech, 2015, 180¨C188) |
2Â¥2015-06-13 10:36:27
nakerunner
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 1011.6
- É¢½ð: 25
- Ìû×Ó: 132
- ÔÚÏß: 165.9Сʱ
- ³æºÅ: 287501
- ×¢²á: 2006-10-21
- ÐÔ±ð: GG
- רҵ: ÁÙ´²¼ìÑéм¼Êõ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
ÍôæÃ·ãÒ¶: ½ð±Ò+3, ¡ï¡ï¡ïºÜÓаïÖú 2015-06-14 16:49:31
ÍôæÃ·ãÒ¶: ½ð±Ò+3, ¡ï¡ï¡ïºÜÓаïÖú 2015-06-14 16:49:31
|
Duplex-specific nuclease-mediated bioanalysis (Trend Biotech, 2015, 180¨C188) ÕâÆªÎÄÕµÄÁ´½ÓÈçÏ£º http://www.sciencedirect.com/sci ... i/S0167779915000025 |
3Â¥2015-06-13 10:37:37
ÍôæÃ·ãÒ¶
гæ (ÕýʽдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 16.3
- É¢½ð: 1005
- ºì»¨: 13
- Ìû×Ó: 510
- ÔÚÏß: 148.8Сʱ
- ³æºÅ: 2646412
- ×¢²á: 2013-09-11
- רҵ: ÁÙ´²¼ìÑéм¼Êõ

4Â¥2015-06-14 14:35:10









»Ø¸´´ËÂ¥
ͶƱ: